CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.

1:22-cv-00925

Overview

Case Number 1:22-cv-00925
Filing Date 2022-07-12
Status Terminated
Termination Date 2023-08-30
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Moderna US, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

ModernaTX, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Moderna, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Alnylam Pharmaceuticals, Inc. Operating Company

Represented By

5 Attorneys Listed

William G. Gaede , III

Email: wgaede@mwe.com

Sarah J. Fischer

Email: sjfischer@mwe.com

Sarah Chapin Columbia

Email: scolumbia@mwe.com

Ian B. Brooks

Email: ibrooks@mwe.com

Ethan Haller Townsend

McDermott Will & Emery LLP

Tel: +1 (302) 485-3911

The Nemours Building, 1007 North Orange Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 7 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 3 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (7): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (3 found):
U.S. Courts: 3
U.S. District Court 2022-07-12
1:22-cv-00924

Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.

Asserted Patent
Status: DED
U.S. District Court 2022-03-17
1:22-cv-00336

Alnylam Pharmaceuticals, Inc. v. Pfizer Inc.

Asserted Patent
Status: DED
U.S. District Court 2022-03-17
1:22-cv-00335

Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11382979
Biodegradable lipids for the delivery of active agents
Filed: 2021-12-17
Issued: 2022-07-12
Active (15.1 yrs remaining)
Expires: 2041-12-17

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Docket Entries

(27 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Moderna US, Inc., Moderna, Inc., ModernaTX, Inc. ( Filing fee $ 402, receipt number ADEDC-3913760.) - filed by Alnylam Pharmaceuticals, Inc. (Attachments: # 1 Exhibit 1-9, # 2 Exhibit 10-26, # 3 Civil Cover Sheet)(apk) (Entered: 07/12/2022)

Entry #1 • 2022-07-12
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Moderna US, Inc., Moderna, Inc., ModernaTX, Inc. ( Filing fee $ 402, receipt number ADEDC-3913760.) - filed by Alnylam Pharmaceuticals, Inc. (Attachments: # 1 Exhibit 1-9, # 2 Exhibit 10-26, # 3 Civil Cover Sheet)(apk) (Entered: 07/12/2022)

Entry #1 • 2022-07-12
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Moderna US, Inc., Moderna, Inc., ModernaTX, Inc. ( Filing fee $ 402, receipt number ADEDC-3913760.) - filed by Alnylam Pharmaceuticals, Inc. (Attachments: # 1 Exhibit 1-9, # 2 Exhibit 10-26, # 3 Civil Cover Sheet)(apk) (Entered: 07/12/2022)

Entry #1 • 2022-07-12
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Moderna US, Inc., Moderna, Inc., ModernaTX, Inc. ( Filing fee $ 402, receipt number ADEDC-3913760.) - filed by Alnylam Pharmaceuticals, Inc. (Attachments: # 1 Exhibit 1-9, # 2 Exhibit 10-26, # 3 Civil Cover Sheet)(apk) (Entered: 07/12/2022)

Entry #1 • 2022-07-12
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 07/12/2022)

Entry #2 • 2022-07-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc